Canada markets closed

Applied Therapeutics, Inc. (APLT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
4.2800+0.0500 (+1.18%)
At close: 04:00PM EDT
4.2800 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 488.95M
Enterprise Value 439.83M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)36.08
Price/Book (mrq)4.89
Enterprise Value/Revenue 44.01
Enterprise Value/EBITDA -6.85

Trading Information

Stock Price History

Beta (5Y Monthly) 1.81
52-Week Change 3137.78%
S&P500 52-Week Change 322.36%
52 Week High 39.3900
52 Week Low 31.1800
50-Day Moving Average 35.8043
200-Day Moving Average 33.1432

Share Statistics

Avg Vol (3 month) 31.81M
Avg Vol (10 day) 3937.03k
Shares Outstanding 5114.24M
Implied Shares Outstanding 6114.24M
Float 887.82M
% Held by Insiders 16.66%
% Held by Institutions 164.41%
Shares Short (Apr 15, 2024) 44.74M
Short Ratio (Apr 15, 2024) 44.93
Short % of Float (Apr 15, 2024) 44.64%
Short % of Shares Outstanding (Apr 15, 2024) 44.15%
Shares Short (prior month Mar 15, 2024) 43.79M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)3,149.63%

Management Effectiveness

Return on Assets (ttm)-86.56%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)9.99M
Revenue Per Share (ttm)0.12
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -64.53M
Net Income Avi to Common (ttm)-119.76M
Diluted EPS (ttm)-1.4200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)49.9M
Total Cash Per Share (mrq)0.47
Total Debt (mrq)777k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.76
Book Value Per Share (mrq)-0.20

Cash Flow Statement

Operating Cash Flow (ttm)-55.17M
Levered Free Cash Flow (ttm)7.74M